Showing results (491-500 of 604) with videos related to

Sort By:
Pageof 61
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2014
Activation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fractionPatrick J Brennan, Raju V V Tatituri, Christian Heiss, et al.
Cureus|June 28, 2021
Emergent Radiotherapy for Leukemia-Induced Cranial Neuropathies Refractory to Intrathecal TherapyNirav Patel, Benjamin J RIch, Shareen Patel, et al.
Leukemia & Lymphoma|March 28, 2024
Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (mIDH1) acute myeloid leukemia (AML)Jorge Cortes, Brian A Jonas, Gary Schiller, et al.
The American Journal of Tropical Medicine and Hygiene|September 3, 2010
Guaroa virus infection among humans in Bolivia and PeruPatricia V Aguilar, Amy C Morrison, Claudio Rocha, et al.
AIDS (London, England)|September 14, 2000
Emerging genetic diversity of HIV-1 in South AmericaK L Russell, C Carcamo, D M Watts, et al.
The American Journal of Tropical Medicine and Hygiene|June 26, 2001
Hepatitis C in Peru: risk factors for infection, potential iatrogenic transmission, and genotype distributionJ L Sanchez, M H Sjogren, J D Callahan, et al.
Leukemia Research|August 30, 2016
Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemiaJustin M Watts, Bogdan Dumitriu, Patrick Hilden, et al.
Blood Advances|July 16, 2025
Olutasidenib alone or combined with azacitidine in patients with mutant IDH1 myelodysplastic syndromeJorge E Cortes, Jay Yang, Gail J Roboz, et al.
British Journal of Haematology|December 19, 2024
Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasmStéphane De Botton, Christian Récher, Jorge Cortes, et al.
British Journal of Haematology|June 27, 2015
Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer CenterJustin M Watts, Ashwin Kishtagari, Meier Hsu, et al.
Pageof 61